Biochemical and Biophysical Research Communications
Celastrol induces expression of heme oxygenase-1 through ROS/Nrf2/ARE signaling in the HaCaT cells
Highlights
► In HaCaT cells, celastrol-induced HO-1 expression was dependent on ROS generation. ► ERK and p38 MAPK were major MAPK pathways responsible for celastrol-induced HO-1 expression. ► Celastrol induced Nrf2 activation. ► Celastrol can activate the ROS-ERK/p38-Nrf2-ARE signaling cascades leading to the upregulation of HO-1 in the keratinocytes.
Introduction
Celastrol, a quinone methide triterpenoid derived from Tripterygium wilfordii Hook, has been used as a traditional medicine for the treatment of various diseases such as inflammation [1]. Celastrol has been demonstrated to exert anti-oxidant, anti-tumor, and anti-inflammatory activities in a variety of in vitro and in vivo models [2], [3], [4]. However, the molecular mechanism by which celastrol exerts its biological activities has not been fully elucidated (for review, see [5]). Celastrol has been shown to suppress production of pro-inflammatory cytokines such as IL-6, TNF-α, and IL-1β by modulating NF-κB signaling pathways in LPS-stimulated cells [6], [7], [8]. Celastrol exhibited its anti-allergic activity by inhibiting FcepsilonRI signaling through binding to ERK in antigen-stimulated mast cells [9]. Recently, we observed that celastrol suppresses IFN-γ-induced ICAM-1 expression and subsequent monocyte adhesiveness by a mechanism involving expression of HO-1 in the keratinocytes [10].
Heme oxygenase-1 (HO-1), an inducible antioxidant enzyme, mediates the degradation of heme into ferrous iron, carbon monoxide (CO) and biliverdin. The products resulting from HO-1 activity have antioxidant and anti-inflammatory effects [11]. In response to oxidative stress, the epidermal keratinocyte, the major cell type in the skin, can express HO-1. Increased HO-1 activity in the skin has been reported to exert cytoprotective and anti-inflammatory effects in several pathological conditions including inflammation [12]. Recently, it was demonstrated that HO-1 expression has a regulatory role in skin inflammation such as atopic dermatitis [13], [14], [15].
Although we reported that celastrol induced HO-1 expression, its signaling pathways involved in the up-regulation of HO-1 expression were not elucidated. In this study, we investigated the signaling cascades that mediate celastrol-induced HO-1 expression in a human keratinocyte cell line HaCaT. We show that celastrol induces HO-1 expression via ROS-ERK/p38-Nrf2-ARE signaling cascades in the HaCaT cells.
Section snippets
Cell culture and reagents
The immortalized human keratinocyte cell line, HaCaT, was maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum and antibiotics (100 U/ml penicillin G, 100 μg/ml streptomycin) at 37 °C in a humidified incubator containing 5% CO2 and 95% air. Human THP-1 monocytic cells were maintained in RPMI 1640 medium supplemented with 2 mM l-glutamine and 10% fetal bovine serum. Nrf2 specific siRNA, control siRNA, primary antibodies against ICAM-1, HO-1, Nrf2, actin,
Generation of ROS by celastrol in HaCaT cells
In the previous study, we demonstrated that HO-1 expression plays a role in the anti-inflammatory responses by celastrol in the keratinocytes [10]. We further studied the signaling pathway leading to HO-1 expression by celastrol. Since the antioxidant enzymes such as HO-1 are known to respond to a variety of oxidative stresses [11], ROS may be involved in celastrol-induced up-regulation of HO-1 expression by human keratinocytes. We investigated ROS generation in the HaCaT cells treated with
Discussion
Infiltration of monocytes/T cells into the inflamed skin is a characteristic feature of skin inflammation. Up-regulation of adhesion molecules such as ICAM-1 in the keratinocytes is an important regulator to initiate interaction between monocytes/T cells and keratinocytes during the processes of skin inflammation [17]. Therefore, suppression of ICAM-1 expression is considered one of strategies for treatment of inflammatory skin diseases. We recently reported that celastrol exerted its
Acknowledgments
This work was supported by the Regional Core Research Program funded by the Korea Ministry of Education, Science and Technology (MEST) (Medical & Bio-material Research Center) and in part by Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0093812).
References (25)
- et al.
Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer’s disease
Prog. Neuropsychopharmacol. Biol. Psychiatry
(2001) - et al.
The triterpene celastrol as a very potent inhibitor of lipid peroxidation in mitochondria
Biochem. Biophys. Res. Commun.
(1990) - et al.
Celastrol: molecular targets of Thunder God Vine
Biochem. Biophys. Res. Commun.
(2010) - et al.
Celastrol inhibits pro-inflammatory cytokine secretion in Crohn’s disease biopsies
Biochem. Biophys. Res. Commun.
(2004) - et al.
Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid
Biochem. Pharmacol.
(2006) - et al.
Celastrol binds to ERK and inhibits FcepsilonRI signaling to exert an anti-allergic effect
Eur. J. Pharmacol.
(2009) - et al.
Celastrol suppresses IFN-gamma-induced ICAM-1 expression and subsequent monocyte adhesiveness via the induction of heme oxygenase-1 in the HaCaT cells
Biochem Biophys Res Commun.
(2010) - et al.
Overexpression of HO-1 protects against TNF-alpha-mediated airway inflammation by down-regulation of TNFR1-dependent oxidative stress
Am. J. Pathol.
(2009) - et al.
Thunder of God Vine, is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice
Cancer Res.
(2006) - et al.
Suppression of inflammatory responses by celastrol, a quinone methide triterpenoid isolated from Celastrus regelii
Eur. J. Clin. Invest.
(2009)
Celastrol inhibits production of nitric oxide and proinflammatory cytokines through MAPK signal transduction and NF-kappaB in LPS-stimulated BV-2 microglial cells
Exp. Mol. Med.
Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications
Physiol. Rev.
Cited by (63)
Live-cell imaging Unveils stimulus-specific dynamics of Nrf2 activation in UV-exposed melanoma cells: Implications for antioxidant compound screening
2024, Free Radical Biology and MedicineCelastrol alleviates oxidative stress induced by multi-walled carbon nanotubes through the Keap1/Nrf2/HO-1 signaling pathway
2023, Ecotoxicology and Environmental SafetySkin biological responses to urban pollution in an ex vivo model
2021, Toxicology LettersSkin photo-protection with phytochemicals against photo-oxidative stress, photo-carcinogenesis, signal transduction pathways and extracellular matrix remodeling—An overview
2020, Ageing Research ReviewsCitation Excerpt :This excited state either releases energy upon returning to the ground state in the form of heat or transits it to a triplet-excited state. The unstable triplet-excited state reacts with molecular oxygen and produces ROS such as superoxide anion (O2−), singlet oxygen (1O2), hydroxyl radical (•OH) and hydrogen peroxide (H2O2) (de Jager et al., 2017; Deng et al., 2018; Seo et al., 2011). These on further react with proteins, DNA, RNA, and lipids, incurring oxidative damages to these macromolecules (Perluigi et al., 2010).
Celastrol: Progresses in structure-modifications, structure-activity relationships, pharmacology and toxicology
2020, European Journal of Medicinal ChemistryApplication of quality by design approach to formulate and optimize tripterine loaded in nanostructured lipid carriers for transdermal delivery
2019, Journal of Drug Delivery Science and Technology
- 1
These authors equally contributed.